Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | May 5, 2014
Finance

Highlights of weekly biotech stock moves

Regulatory, clinical and other milestones
BioCentury | Apr 29, 2014
Company News

Forest to acquire Furiex

BioCentury | Sep 9, 2013
Emerging Company Profile

Ixchelsis: Lasting longer

Ixchelsis targeting the oxytocin receptor to delay ejaculation more safely
BioCentury | Apr 8, 2013
Company News

Furiex Pharmaceuticals, Menarini deal

BioCentury | Aug 6, 2012
Company News

Furiex Pharmaceuticals, J&J, Menarini deal

Items per page:
1 - 10 of 33